APA (7th ed.) Citation

EP, J., DR, P., S, T., B, G., S, A., KC, B., . . . IF, P. (2020). Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance. Molecular cancer research : MCR, 18(7), 1004. https://doi.org/10.1158/1541-7786.MCR-19-0669

Chicago Style (17th ed.) Citation

EP, Jane, et al. "Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance." Molecular Cancer Research : MCR 18, no. 7 (2020): 1004. https://doi.org/10.1158/1541-7786.MCR-19-0669.

MLA (9th ed.) Citation

EP, Jane, et al. "Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance." Molecular Cancer Research : MCR, vol. 18, no. 7, 2020, p. 1004, https://doi.org/10.1158/1541-7786.MCR-19-0669.